Abstract
Patients with bipolar disorder have been found to have high rates of endocrine and cardiovascular disorders as well as obesity. Some health problems may be influenced by the psychiatric disorder itself, and, similarly, health problems may influence the course of bipolar disorder. Further, some pharmacologic treatments used for bipolar disorder have been associated with obesity, diabetes, hyperglycemia, dyslipidemia, metabolic syndrome, prolonged QTc, and thyroid dysfunction. To optimize care and achieve the best possible treatment outcomes, integrated psychiatric and medical care is needed.
MeSH terms
-
Antipsychotic Agents / adverse effects*
-
Antipsychotic Agents / therapeutic use
-
Bipolar Disorder / diagnosis*
-
Bipolar Disorder / epidemiology*
-
Diabetes Complications
-
Dyslipidemias / chemically induced
-
Dyslipidemias / epidemiology
-
Humans
-
Hyperglycemia / chemically induced
-
Hyperglycemia / epidemiology
-
Long QT Syndrome / chemically induced
-
Long QT Syndrome / epidemiology
-
Metabolic Syndrome / chemically induced
-
Metabolic Syndrome / epidemiology
-
Monitoring, Physiologic*
-
Obesity / chemically induced
-
Obesity / epidemiology
-
Thyroid Diseases / chemically induced
-
Thyroid Diseases / epidemiology